Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Open, Comparative, Within Patient Controlled Multicenter Phase 3 Study of Blue Light Cystoscopy With Cysview and White Light Cystoscopy Using KARL STORZ D-Light C PDD Flexible Videoscope System in Detection of Bladder Cancer in Patients With Bladder Cancer

Next Previous
Trial Profile

A Prospective, Open, Comparative, Within Patient Controlled Multicenter Phase 3 Study of Blue Light Cystoscopy With Cysview and White Light Cystoscopy Using KARL STORZ D-Light C PDD Flexible Videoscope System in Detection of Bladder Cancer in Patients With Bladder Cancer

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hexyl aminolevulinate (Primary)
  • Indications Bladder cancer
  • Focus Diagnostic use; Registrational
  • Acronyms BRAVO
  • Sponsors PhotoCure

Most Recent Events

  • 19 Feb 2023 According to Photocure media release, the company has announced the presentation of clinical trial data from this study at the ASCO Genitourinary Cancers Symposium (ASCO GU) which was held in 16th-18th February.
  • 06 Jul 2018 Results (n=304) published in the BJU International.
  • 16 Feb 2018 According to a Photocure media release, based on the results from this study, the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for use of Blue Light Cystoscopy (BLC(TM)) with Cysview for use during surveillance cystoscopy to detect recurrence of bladder cancer using a flexible cystoscope.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top